From yesterday Proactive, For study phase 2 we
Post# of 148168
(Total Views: 533)
Posted On: 04/07/2020 8:41:20 AM
From yesterday Proactive,
For study phase 2 we need 75 patients , they should be enroll within 10 days or so. ...at about 4:02
For phase 2b/3 severe patients , Dr NP said yesterday that they need 350 patients , but when they will have 50 they will prepare interim result and present to FDA.
This 50 patients should be enroll in 2-3 weeks - about 4:20
Endpoint for phase 2b/3 is for every patient , 2 weeks after starting treatment.
In today PR they said we need 390 patients for 2b/3 study , I will think this number is a mistake.
For study phase 2 we need 75 patients , they should be enroll within 10 days or so. ...at about 4:02
For phase 2b/3 severe patients , Dr NP said yesterday that they need 350 patients , but when they will have 50 they will prepare interim result and present to FDA.
This 50 patients should be enroll in 2-3 weeks - about 4:20
Endpoint for phase 2b/3 is for every patient , 2 weeks after starting treatment.
In today PR they said we need 390 patients for 2b/3 study , I will think this number is a mistake.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼